Annual Report

The report describes Pharming's 2021 revenue of US$198.9 million, alongside continued growth to 321 employees at year-end. It highlights increased board diversity, with three women among eight executive and non-executive directors. The report also begins a formal ESG journey, including plans for an ESG committee and baseline assessment, while continuing its focus on patient safety, animal welfare, employee well-being, and ethical conduct.